{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:25:22Z","timestamp":1787005522065,"version":"build-2736575974"},"reference-count":33,"publisher":"CSIRO Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":701,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To assess whether compliance with the nationally endorsed Optimal Care Pathways is evident in 75% of patients treated with curative intent treatment and if this compliance was impacted by the COVID-19 pandemic (hereinafter COVID-19).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included patients undergoing curative treatment with radiotherapy in head and neck (HN), breast, lung and gastrointestinal malignancies between January 2019 and June 2021 in a single NSW outer metropolitan cancer service. For care delivered within the remit of cancer services, the primary outcome measure was the proportion of patients whose treatment complied with the Optimal Care Pathways recommended time frame. Secondary outcome measures included evaluating the effect of COVID-19 on the proportion of patients being treated within the recommended time frame.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were n\u00a0=\u00a0733 eligible patients across the five tumour streams with the majority being breast cancer patients comprising 65% (n\u00a0=\u00a0479) of the cohort, followed by HN cancer patients (n\u00a0=\u00a0125, 17%). None of the tumour subsites abided by the 75% compliance rate. Oesophageal cancer patients had the lowest compliance rate of 4% (P\u00a0&amp;lt;\u00a00.001), with a similarly low compliance rate for rectal cancer patients at 33% (P\u00a0=\u00a00.002). None of the hypothesis tests to assess for detriment in treatment time during COVID-19 were statistically significant (P\u00a0&amp;gt;\u00a00.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite the availability of best practice guidelines, there is limited compliance throughout all cancer subtypes, which has not been negatively influenced by COVID-19. Improved awareness of the Optimal Care Pathways, and implementation of the associated infrastructure and systems, are required to support compliance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/ah23060","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T17:41:56Z","timestamp":1687887716000},"page":"472-479","source":"Crossref","is-referenced-by-count":11,"title":["Optimal cancer care pathways \u2013 the ideal versus reality for patient-centric cancer care during COVID-19"],"prefix":"10.1071","volume":"47","author":[{"given":"Shanuka","family":"Samaranayake","sequence":"first","affiliation":[{"name":"AWestmead Hospital, Hawkesbury Road, Westmead, NSW 2145, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barker","sequence":"additional","affiliation":[{"name":"BFaculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia."},{"name":"CHunter Medical Research Institute, Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apsara","family":"Windsor","sequence":"additional","affiliation":[{"name":"BFaculty of Health and Medicine, University of Newcastle, Callaghan, NSW 2308, Australia."},{"name":"DGosford Hospital, Holden Street, Gosford, NSW 2250, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"issue":"2","key":"2025121501274761000_R1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10549-019-05404-8","article-title":"Time-to-surgery and overall survival after breast cancer diagnosis in a universal health system.","volume":"178","author":"Eaglehouse","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"2025121501274761000_R2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4087","article-title":"Mortality due to cancer treatment delay: systematic review and meta-analysis.","volume":"371","author":"Hanna","year":"2020","journal-title":"BMJ"},{"issue":"2","key":"2025121501274761000_R3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1200\/JCO.2015.61.5906","article-title":"Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.","volume":"34","author":"Murphy","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"2025121501274761000_R4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/ajco.13505","article-title":"An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.","volume":"17","author":"Degeling","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"2025121501274761000_R5","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.662339","article-title":"Psychosocial Impact of Cancer Care Disruptions in Women With Breast Cancer During the COVID-19 Pandemic.","volume":"12","author":"Soriano","year":"2021","journal-title":"Front Psychol"},{"key":"2025121501274761000_R6"},{"key":"2025121501274761000_R7"},{"key":"2025121501274761000_R8"},{"issue":"S1","key":"2025121501274761000_R9","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1038\/bjc.2015.44","article-title":"A differentiated approach to referrals from general practice to support early cancer diagnosis \u2013 the Danish three-legged strategy.","volume":"112","author":"Vedsted","year":"2015","journal-title":"Br J Cancer"},{"key":"2025121501274761000_R10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.eclinm.2019.08.009","article-title":"Alignment with indices of a care pathway is associated with improved survival.","volume":"15","author":"te Marvelde","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"1","key":"2025121501274761000_R11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3623-8","article-title":"Prognostic consequences of implementing cancer patient pathways in Denmark: A comparative cohort study of symptomatic cancer patients in primary care.","volume":"17","author":"Jensen","year":"2017","journal-title":"BMC Cancer"},{"issue":"8","key":"2025121501274761000_R12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol"},{"issue":"7","key":"2025121501274761000_R13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/imj.14465","article-title":"Improving regional lung cancer optimal care pathway compliance through a rapid-access respiratory clinic.","volume":"50","author":"Jeyakumar","year":"2020","journal-title":"Intern Med J"},{"issue":"2","key":"2025121501274761000_R14","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58020145","article-title":"Delays in Time to Head and Neck Cancer Treatment: A South Australian Perspective.","volume":"58","author":"Cook","year":"2022","journal-title":"Medicina"},{"issue":"2","key":"2025121501274761000_R15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/1754-9485.13167","article-title":"Oesophageal cancer treatment patterns, timeliness of care and outcomes in the Loddon Mallee region of Victoria: A retrospective cohort study.","volume":"65","author":"Conway","year":"2021","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"2025121501274761000_R16","doi-asserted-by":"publisher","DOI":"10.1111\/ecc.13649","article-title":"Variation in ovarian cancer care in Australia: An analysis of patterns of care in diagnosis and initial treatment in New South Wales.","volume":"31","author":"White","year":"2022","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"2025121501274761000_R17","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pec.2018.09.015","article-title":"Decision-making under clinical uncertainty: An in-depth examination of provider perspectives on adjuvant chemotherapy for stage II colon cancer.","volume":"102","author":"Shelton","year":"2019","journal-title":"Patient Educ Couns"},{"key":"2025121501274761000_R18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/bju.13037","article-title":"Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.","volume":"117","author":"Brown","year":"2016","journal-title":"BJU Int"},{"issue":"7","key":"2025121501274761000_R19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5694\/j.1326-5377.1997.tb125101.x","article-title":"Local impact of the NHMRC early breast cancer guidelines: Where to from here?","volume":"167","author":"Ward","year":"1997","journal-title":"Med J Aust"},{"key":"2025121501274761000_R20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.17.00136","article-title":"Oncology guidelines usage in a low-and middle-income country.","volume":"4","author":"Ismaila","year":"2018","journal-title":"J Glob Oncol"},{"key":"2025121501274761000_R21"},{"key":"2025121501274761000_R22"},{"key":"2025121501274761000_R23"},{"issue":"1","key":"2025121501274761000_R24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-9-31","article-title":"Pathways to the diagnosis of lung cancer in the UK: A cohort study.","volume":"9","author":"Barrett","year":"2008","journal-title":"BMC Fam Pract"},{"issue":"1","key":"2025121501274761000_R25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/fampra\/cmi093","article-title":"Pathways to the diagnosis of colorectal cancer: An observational study in three UK cities.","volume":"23","author":"Barrett","year":"2005","journal-title":"Fam Pract"},{"key":"2025121501274761000_R26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1200\/CCI.20.00134","article-title":"Impact of covid-19 on cancer care: How the pandemic is delaying cancer diagnosis and treatment for American seniors.","volume":"4","author":"Patt","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"2025121501274761000_R27"},{"key":"2025121501274761000_R28"},{"key":"2025121501274761000_R29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv347.12","article-title":"Distance as a barrier to cancer diagnosis and treatment: Review of the literature.","volume":"26","author":"Ambroggi","year":"2015","journal-title":"Ann Oncol"},{"key":"2025121501274761000_R30"},{"key":"2025121501274761000_R31"},{"issue":"2","key":"2025121501274761000_R32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3322\/canjclin.54.2.78","article-title":"Cancer disparities by race\/ethnicity and socioeconomic status.","volume":"54","author":"Ward","year":"2004","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"2025121501274761000_R33","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/bjc.2017.127","article-title":"Comorbid conditions delay diagnosis of colorectal cancer: A cohort study using electronic primary care records.","volume":"116","author":"Mounce","year":"2017","journal-title":"Br J Cancer"}],"container-title":["Australian Health Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/47\/4\/472\/443671\/ah23060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/ah\/article-pdf\/47\/4\/472\/443671\/ah23060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:27:52Z","timestamp":1765780072000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/ah\/article\/47\/4\/472\/71776\/Optimal-cancer-care-pathways-the-ideal-versus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8,3]]}},"URL":"https:\/\/doi.org\/10.1071\/ah23060","relation":{},"ISSN":["0156-5788","1449-8944"],"issn-type":[{"value":"0156-5788","type":"print"},{"value":"1449-8944","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]}}}